These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30034232)

  • 1. Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for the treatment of Alzheimer's disease.
    Binda A; Panariti A; Barbuti A; Murano C; Dal Magro R; Masserini M; Re F; Rivolta I
    Int J Nanomedicine; 2018; 13():4059-4071. PubMed ID: 30034232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: implications for therapy of Alzheimer disease.
    Bana L; Minniti S; Salvati E; Sesana S; Zambelli V; Cagnotto A; Orlando A; Cazzaniga E; Zwart R; Scheper W; Masserini M; Re F
    Nanomedicine; 2014 Oct; 10(7):1583-90. PubMed ID: 24333591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional Liposomes Modulate Purinergic Receptor-Induced Calcium Wave in Cerebral Microvascular Endothelial Cells and Astrocytes: New Insights for Alzheimer's disease.
    Forcaia G; Formicola B; Terribile G; Negri S; Lim D; Biella G; Re F; Moccia F; Sancini G
    Mol Neurobiol; 2021 Jun; 58(6):2824-2835. PubMed ID: 33511502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models.
    Balducci C; Mancini S; Minniti S; La Vitola P; Zotti M; Sancini G; Mauri M; Cagnotto A; Colombo L; Fiordaliso F; Grigoli E; Salmona M; Snellman A; Haaparanta-Solin M; Forloni G; Masserini M; Re F
    J Neurosci; 2014 Oct; 34(42):14022-31. PubMed ID: 25319699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease.
    Mancini S; Minniti S; Gregori M; Sancini G; Cagnotto A; Couraud PO; Ordóñez-Gutiérrez L; Wandosell F; Salmona M; Re F
    Nanomedicine; 2016 Jan; 12(1):43-52. PubMed ID: 26410276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease.
    Mancini S; Balducci C; Micotti E; Tolomeo D; Forloni G; Masserini M; Re F
    J Control Release; 2017 Jul; 258():121-129. PubMed ID: 28501671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized liposomes with transactivator of transcription peptide and anti-apoptotic drugs to target hippocampal neurons and prevent tau-hyperphosphorylated neurodegeneration.
    Kuo YC; Chen CL; Rajesh R
    Acta Biomater; 2019 Mar; 87():207-222. PubMed ID: 30716553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multifunctional Biocompatible Drug Candidate is Highly Effective in Delaying Pathological Signs of Alzheimer's Disease in 5XFAD Mice.
    Segal-Gavish H; Danino O; Barhum Y; Ben-Zur T; Shai E; Varon D; Offen D; Fischer B
    J Alzheimers Dis; 2017; 58(2):389-400. PubMed ID: 28453480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RVG29-Functionalized Lipid Nanoparticles for Quercetin Brain Delivery and Alzheimer's Disease.
    Pinheiro RGR; Granja A; Loureiro JA; Pereira MC; Pinheiro M; Neves AR; Reis S
    Pharm Res; 2020 Jul; 37(7):139. PubMed ID: 32661727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
    Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
    Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
    Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
    PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in CA1 pyramidal neuronal intrinsic excitability mediated by Ih channel currents in a rat model of amyloid beta pathology.
    Eslamizade MJ; Saffarzadeh F; Mousavi SM; Meftahi GH; Hosseinmardi N; Mehdizadeh M; Janahmadi M
    Neuroscience; 2015 Oct; 305():279-92. PubMed ID: 26254243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide.
    Taylor M; Moore S; Mourtas S; Niarakis A; Re F; Zona C; La Ferla B; Nicotra F; Masserini M; Antimisiaris SG; Gregori M; Allsop D
    Nanomedicine; 2011 Oct; 7(5):541-50. PubMed ID: 21722618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide.
    Re F; Cambianica I; Sesana S; Salvati E; Cagnotto A; Salmona M; Couraud PO; Moghimi SM; Masserini M; Sancini G
    J Biotechnol; 2011 Dec; 156(4):341-6. PubMed ID: 21763360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-amyloid peptides increase the binding and internalization of apolipoprotein E to hippocampal neurons.
    Beffert U; Aumont N; Dea D; Lussier-Cacan S; Davignon J; Poirier J
    J Neurochem; 1998 Apr; 70(4):1458-66. PubMed ID: 9523562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applicability of [
    Snellman A; Rokka J; López-Picón FR; Helin S; Re F; Löyttyniemi E; Pihlaja R; Forloni G; Salmona M; Masserini M; Solin O; Rinne JO; Haaparanta-Solin M
    Neurobiol Aging; 2017 Sep; 57():84-94. PubMed ID: 28605642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve Growth Factor Gene Delivery across the Blood-Brain Barrier to Reduce Beta Amyloid Accumulation in AD Mice.
    Rodrigues BDS; Kanekiyo T; Singh J
    Mol Pharm; 2020 Jun; 17(6):2054-2063. PubMed ID: 32315185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice.
    Ordóñez-Gutiérrez L; Re F; Bereczki E; Ioja E; Gregori M; Andersen AJ; Antón M; Moghimi SM; Pei JJ; Masserini M; Wandosell F
    Nanomedicine; 2015 Feb; 11(2):421-30. PubMed ID: 25461285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wheat germ agglutinin-conjugated liposomes incorporated with cardiolipin to improve neuronal survival in Alzheimer's disease treatment.
    Kuo YC; Lin CY; Li JS; Lou YI
    Int J Nanomedicine; 2017; 12():1757-1774. PubMed ID: 28280340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM1-Modified Lipoprotein-like Nanoparticle: Multifunctional Nanoplatform for the Combination Therapy of Alzheimer's Disease.
    Huang M; Hu M; Song Q; Song H; Huang J; Gu X; Wang X; Chen J; Kang T; Feng X; Jiang D; Zheng G; Chen H; Gao X
    ACS Nano; 2015 Nov; 9(11):10801-16. PubMed ID: 26440073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.